CDK2 and nonpapillary renal cell carcinoma: Nearly all regions of all tumors demonstrated down-regulation of hsa-miR-200c-3p, a suppressor of the CDK2 cell-cycle progression regulator, hsa-miR-135a-5p, a suppressor of the MYC oncogene, and hsa-miR-141-3p, a regulator of proliferation and metastasis in ccRCC 25-27.